The Swedish Prison Program is an Intervention Prevention Program Targeting Injecting Drug Users Risk Behaviours and Infectious Diseases


The purpose of the Swedish Prison Program which started back in 1987 and up until 2009 was called "The Social Medicine Remand Prison Project" is to target injecting drug users (IDU) with primary and secondary health interventions with regards to injecting and sexual risk behaviours and infectious diseases such as hepatitis C and B, HIV and sexually transmitted infections (STI). The overall aim is to assess the effect of different prevention efforts on HIV/HCV risk behaviour and disease outcome among IDUs over time.

Full Title of Study: “Svenska H√§ktesprogrammet, Prevention, Risk Behaviour and Infectious Diseases Among IDU.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Primary Purpose: Prevention
  • Study Primary Completion Date: December 2013

Detailed Description

Risk behaviour for IDU is sexual risk taking, i.e., sex without a condom, buying or selling sex and injection risk taking, i.e., sharing needle, syringe or paraphernalia.


  • Behavioral: Risk behaviour and infectious diseases
    • through counselling, testing vaccination

Arms, Groups and Cohorts

  • Other: Risk behaviour and infectious diseases
    • .(among IDU)

Clinical Trial Outcome Measures

Primary Measures

  • Number of participants with injection risk behaviour
    • Time Frame: 2002-2012
    • Have you received already used injection equipment from someone last 12 months Have you lent (away) already used injection equipment to someone last 12 months Have you shared solution and/or filter with someone last 12 months Number of people shared needles with last month Number of injections last month Number of Hepatitis C positive Number of HIV positive Number of Hepatitis B positive Number of respondenst positive for sexually transmitted infections

Secondary Measures

  • Number of participants with infectious diseases
    • Time Frame: 2002-2012
    • HIV, HCV, HBV and STI

Participating in This Clinical Trial

Inclusion Criteria

  • Defined as an injecting drug user, in the prison and probation service and agree to anonymously participate Exclusion Criteria:

  • Being defined as a non-drug user, non-injecting drug user

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Karolinska Institutet
  • Collaborator
    • Public Health Agency of Sweden
  • Provider of Information About this Clinical Study
    • Principal Investigator: Niklas Karlsson, PhD candidate – Karolinska Institutet

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.